MVC logo

Metrovacesa S.A. Stock Price

BME:MVC Community·€1.5b Market Cap
  • 3 Narratives written by author
  • 1 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author
Create a narrative

MVC Share Price Performance

€10.20
1.66 (19.44%)
13.6% undervalued intrinsic discount
€11.80
Fair Value
€10.20
1.66 (19.44%)
13.6% undervalued intrinsic discount
€11.80
Fair Value
Price €10.20
AnalystHighTarget €11.80
AnalystConsensusTarget €9.80
AnalystLowTarget €6.50

MVC Community Narratives

AnalystHighTarget·
Fair Value €11.8 13.1% undervalued intrinsic discount

Urbanization And Green Building Will Drive Lasting Value

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value €9.81 4.5% overvalued intrinsic discount

Urban Influx And ESG Excellence Will Fuel Spain's Residential Expansion

0users have liked this narrative
1users have commented on this narrative
0users have followed this narrative
AnalystLowTarget·
Fair Value €6.5 57.7% overvalued intrinsic discount

Soaring House Prices Will Shrink Margins Amid Mounting Compliance Costs

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent MVC News & Updates

Should You Think About Buying Metrovacesa S.A. (BME:MVC) Now?

Oct 02
Should You Think About Buying Metrovacesa S.A. (BME:MVC) Now?

Calculating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Jul 25
Calculating The Fair Value Of Metrovacesa S.A. (BME:MVC)

Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

May 04
Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?

Are Investors Undervaluing Metrovacesa S.A. (BME:MVC) By 40%?

Apr 12
Are Investors Undervaluing Metrovacesa S.A. (BME:MVC) By 40%?

Metrovacesa's (BME:MVC) Performance Is Even Better Than Its Earnings Suggest

Feb 26
Metrovacesa's (BME:MVC) Performance Is Even Better Than Its Earnings Suggest
User avatar

Will Leverage Undersupplied Spanish Housing Market For Future Opportunities

High presales coverage allows focus on margin maximization, boosting future net margins amid an undersupplied market.

Is It Time To Consider Buying Metrovacesa S.A. (BME:MVC)?

Feb 07
Is It Time To Consider Buying Metrovacesa S.A. (BME:MVC)?

Metrovacesa S.A. Key Details

€555.2m

Revenue

€447.9m

Cost of Revenue

€107.3m

Gross Profit

€110.7m

Other Expenses

-€3.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.023
Gross Margin
19.33%
Net Profit Margin
-0.62%
Debt/Equity Ratio
28.8%

Metrovacesa S.A. Competitors

 
 
 
 
 
 
 
 
 
 
 
 
View more competitors

Snowflake Analysis

Excellent balance sheet with reasonable growth potential.

0 Risks
2 Rewards
View Full Analysis

About MVC

Founded
1918
Employees
215
CEO
Jorge de Leza Eguiguren
WebsiteView website
www.metrovacesa.com

Metrovacesa S.A. operates as a real estate development company in Spain. It develops and sells residential and commercial premises, as well as sells land. The company was founded in 1918 and is based in Madrid, Spain.

Market Insight

Header cover image

📈 Markets Break Records: Q3 2025 in Review, Q4 Outlook Ahead

Richard Bowman avatarRichard Bowman
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Last Week
✨Rare Earths: Tiny Market, Outsized Influence

✨Rare Earths: Tiny Market, Outsized Influence

Spanish Market Performance

  • 7 Days: -0.9%
  • 3 Months: 8.7%
  • 1 Year: 24.6%
  • Year to Date: 26.4%
In the last week, the market has been flat, with a notable exception in the Healthcare sector dropping 3.8%. Meanwhile, the market is actually up 25% over the past year. As for the next few years, earnings are expected to grow by 5.1% per annum. Market details ›